12:00 AM
Sep 21, 2015
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Acino sales and marketing update

Acino launched a generic version of Exelon Patch rivastigmine from Novartis AG (NYSE:NVS; SIX:NOVN, Basel,...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >